NCT02095509View on ClinicalTrials.gov

Pharmacokinetics of Enoxaparin in Intensive Care Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2016

Conditions
Venous Thromboembolism
Interventions
DRUG

Enoxaparin

Drug class: Low-molecular weight heparin

Trial Locations (2)

33521

Tampere University Hospital, Tampere

00029

Helsinki University Central Hospital, Meilahti, Helsinki

All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

lead

Tampere University Hospital

OTHER

NCT02095509 - Pharmacokinetics of Enoxaparin in Intensive Care Patients | Biotech Hunter | Biotech Hunter